Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cognetivity Neurosciences (DE:1UB)
FRANKFURT:1UB
Cognetivity Neurosciences (1UB) Stock Price & Analysis
0 Followers
1UB Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range<€0.01 - €0.22
Previous Close€0.01
Volume0.00
Average Volume (3M)1.07K
Market Cap
€912.23K
Enterprise Value€1.83M
Total Cash (Recent Filing)C$16.57K
Total Debt (Recent Filing)C$1.37M
Price to Earnings (P/E)N/A
Beta-1.69
Next Earnings
Jun 05, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding89,588,611
10 Day Avg. Volume0
30 Day Avg. Volume1,068
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-0.09
Price to Sales (P/S)4.94
Price to Cash Flow (P/CF)19.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cognetivity Neurosciences News
1UB FAQ
What was Cognetivity Neurosciences’s price range in the past 12 months?
Cognetivity Neurosciences lowest stock price was <€0.01 and its highest was €0.22 in the past 12 months.
What is Cognetivity Neurosciences’s market cap?
Currently, no data Available
When is Cognetivity Neurosciences’s upcoming earnings report date?
Cognetivity Neurosciences’s upcoming earnings report date is Jun 05, 2024 which is in 30 days.
How were Cognetivity Neurosciences’s earnings last quarter?
Cognetivity Neurosciences released its earnings results on Dec 30, 2023. The company reported -€0.02 earnings per share for the quarter, missing the consensus estimate of -€0.014 by -€0.007.
Is Cognetivity Neurosciences overvalued?
According to Wall Street analysts Cognetivity Neurosciences’s price is currently Overvalued.
Does Cognetivity Neurosciences pay dividends?
Cognetivity Neurosciences does not currently pay dividends.
What is Cognetivity Neurosciences’s EPS estimate?
Cognetivity Neurosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cognetivity Neurosciences have?
Currently, no data Available
What happened to Cognetivity Neurosciences’s price movement after its last earnings report?
Cognetivity Neurosciences reported an EPS of -€0.02 in its last earnings report, missing expectations of -€0.014. Following the earnings report the stock price went down -8.333%.
Which hedge fund is a major shareholder of Cognetivity Neurosciences?
Currently, no hedge funds are holding shares in DE:1UB
---
Cognetivity Neurosciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Cognetivity Neurosciences
Cognetivity Neurosciences Ltd is developing a platform technology comprising of a visual stimulus based diagnostic test and artificial intelligence tools to support the early detection and monitoring of cognitive impairment in neurodegenerative diseases, with initial emphasis on dementia in Alzheimer's disease and mild cognitive impairment, a difficult-to-diagnose, "pre-dementia" condition.
---
1UB Stock 12 Months Forecast
Average Price Target
―CytoDyn
―
Marker Therapeutics
―
Adverum Biotechnologies
―
Gritstone Oncology
―
Cognetivity Neurosciences
―
Best Analysts Covering 1UB
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
-43.18%
reiterated a buy rating 7 months ago
Copying Stefan Quenneville's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -43.18% per trade.
---